Brief report - Patients with primary brain tumors as organ donors: Case report and review of the literature

被引:10
作者
Punnett, AS
McCarthy, LJ
Dirks, PB
Hawkins, C
Bouffet, E
机构
[1] Hosp Sick Children, Div Hematol Oncol, Dept Pediat, Pediat Brain Tumor Program, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada
关键词
brain tumor; case report; donor derived malignancy; organ donation;
D O I
10.1002/pbc.20039
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Malignancy is considered a contraindication to organ donation, with a few possible exceptions. We present the case of a child with fatal intracranial hemorrhage from a primary brain tumor (PBT) whose organs were denied for transplant after recovery. We review the literature of organ donors with PBTs in the context of the current organ shortage and discuss the implications for the practicing oncologist. Transmission of donor brain tumor to organ recipients has been documented but the incidence appears to be very low. Risk factors for tumor transmission include underlying donor tumor histology, history of craniotomy and/or shunt placement, use of systemic chemotherapy and radiation therapy, and duration of disease prior to donation. Ongoing data collection by national registries will provide more information on the potential risk to organ recipients. It may be appropriate to expand the donor pool to include donors with PBTs in certain situations. The transplantation team ultimately decides upon the use of organs from specific donors. Many families will appreciate the opportunity to donate specific tissues even if solid organ transplantation is prohibited. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 27 条
[1]
THE RISKS OF METASTASES FROM SHUNTING IN CHILDREN WITH PRIMARY CENTRAL-NERVOUS-SYSTEM TUMORS [J].
BERGER, MS ;
BAUMEISTER, B ;
GEYER, JR ;
MILSTEIN, J ;
KANEV, PM ;
LEROUX, PD .
JOURNAL OF NEUROSURGERY, 1991, 74 (06) :872-877
[2]
Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: A case report [J].
Bosmans, JL ;
Ysebaert, D ;
DeCock, AM ;
Hauben, E ;
Muylle, L ;
Schrijvers, D ;
VanMarck, E ;
Eyskens, E ;
DeBroe, ME .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :838-838
[3]
Donors with central nervous system malignancies: Are they truly safe? [J].
Buell, JF ;
Trofe, J ;
Sethuraman, G ;
Hanaway, MJ ;
Beebe, TM ;
Gross, TG ;
Alloway, R ;
First, MR ;
Woodle, ES .
TRANSPLANTATION, 2003, 76 (02) :340-343
[4]
CAMPBELL AN, 1984, CANCER, V53, P974, DOI 10.1002/1097-0142(19840215)53:4<974::AID-CNCR2820530426>3.0.CO
[5]
2-C
[6]
CHUANG HL, 1997, ADV CLIN NEUROSCI, V7, P47
[7]
Risk of tumor transmission in transplantation from donors with primary brain tumors: An Australian and New Zealand Registry report [J].
Chui, AKK ;
Herbertt, K ;
Wang, LS ;
Kyd, G ;
Hodgeman, G ;
Verran, DJ ;
DeLeon, C ;
Sheil, AGR .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :1266-1267
[8]
COLQUHOUN SD, 1994, TRANSPLANTATION, V57, P970
[9]
Medical progress: Brain tumors [J].
DeAngelis, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) :114-123
[10]
Detry O, 2000, TRANSPLANTATION, V70, P244